Abstract
CD22 is a negative regulator of B-cell receptor signaling, an activity mediated by recruitment of SH2 domain–containing phosphatase 1 through a phosphorylated immunoreceptor tyrosine inhibitory motif in its cytoplasmic domain1. As in other members of the sialic acid–binding immunoglobulin-like lectin, or siglec, family, the extracellular N-terminal immunoglobulin domain of CD22 binds to glycan ligands containing sialic acid, which are highly expressed on B-cell glycoproteins2. B-cell glycoproteins bind to CD22 in cis and 'mask' the ligand-binding domain3, modulating its activity as a regulator of B-cell signaling4,5,6. To assess cell-surface cis ligand interactions, we developed a new method for in situ photoaffinity cross-linking of glycan ligands to CD22. Notably, CD45, surfaceIgM (sIgM) and other glycoproteins that bind to CD22 in vitro7,8 do not appear to be important cis ligands of CD22 in situ. Instead, CD22 seems to recognize glycans of neighboring CD22 molecules as cis ligands, forming homomultimeric complexes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Cyster, J.G. & Goodnow, C.C. Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment. Immunity 6, 509–517 (1997).
Powell, L.D., Jain, R.K., Matta, K.L., Sabesan, S. & Varki, A. Characterization of sialyloligosaccharide binding by recombinant soluble and native cell-associated CD22. Evidence for a minimal structural recognition motif and the potential importance of multisite binding. J. Biol. Chem. 270, 7523–7532 (1995).
Razi, N. & Varki, A. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes. Proc. Natl. Acad. Sci. USA 95, 7469–7474 (1998).
Jin, L., McLean, P.A., Neel, B.G. & Wortis, H.H. Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling. J. Exp. Med. 195, 1199–1205 (2002).
Kelm, S., Gerlach, J., Brossmer, R., Danzer, C.P. & Nitschke, L. The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound. J. Exp. Med. 195, 1207–1213 (2002).
Poe, J.C. et al. CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms. Nat. Immunol. 5, 1078–1087 (2004).
Sgroi, D., Varki, A., Braesch-Andersen, S. & Stamenkovic, I. CD22, a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin. J. Biol. Chem. 268, 7011–7018 (1993).
Hanasaki, K., Powell, L.D. & Varki, A. Binding of human plasma sialoglycoproteins by the B cell-specific lectin CD22. Selective recognition of immunoglobulin M and haptoglobin. J. Biol. Chem. 270, 7543–7550 (1995).
Zhang, M. & Varki, A. Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis. Glycobiology 14, 939–949 (2004).
Oetke, C. et al. Versatile biosynthetic engineering of sialic acid in living cells using synthetic sialic acid analogues. J. Biol. Chem. 277, 6688–6695 (2002).
Luchansky, S.J., Goon, S. & Bertozzi, C.R. Expanding the diversity of unnatural cell-surface sialic acids. ChemBioChem 5, 371–374 (2004).
Shapiro, R.E. et al. Identification of a ganglioside recognition domain of tetanus toxin using a novel ganglioside photoaffinity ligand. J. Biol. Chem. 272, 30380–30386 (1997).
Zaccai, N.R. et al. Structure-guided design of sialic acid-based Siglec inhibitors and crystallographic analysis in complex with sialoadhesin. Structure 11, 557–567 (2003).
Keppler, O.T. et al. UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation. Science 284, 1372–1376 (1999).
Saxon, E. & Bertozzi, C.R. Cell surface engineering by a modified Staudinger reaction. Science 287, 2007–2010 (2000).
Law, C.L., Aruffo, A., Chandran, K.A., Doty, R.T. & Clark, E.A. Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells. J. Immunol. 155, 3368–3376 (1995).
Greer, S.F. & Justement, L.B. CD45 regulates tyrosine phosphorylation of CD22 and its association with the protein tyrosine phosphatase SHP-1. J. Immunol. 162, 5278–5286 (1999).
Fujimoto, M., Bradney, A.P., Poe, J.C., Steeber, D.A. & Tedder, T.F. Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop. Immunity 11, 191–200 (1999).
Chen, J. et al. CD22 attenuates calcium signaling by potentiating plasma membrane calcium-ATPase activity. Nat. Immunol. 5, 651–657 (2004).
D'Arena, G. et al. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features. Haematologica 83, 197–203 (1998).
D'Arena, G. et al. Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders. Am. J. Hematol. 64, 275–281 (2000).
Borowitz, M.J. et al. Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study. Blood 89, 3960–3966 (1997).
Sgroi, D., Nocks, A. & Stamenkovic, I. A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33. J. Biol. Chem. 271, 18803–18809 (1996).
Braesch-Andersen, S. & Stamenkovic, I. Sialylation of the B lymphocyte molecule CD22 by alpha 2,6-sialyltransferase is implicated in the regulation of CD22-mediated adhesion. J. Biol. Chem. 269, 11783–11786 (1994).
Hennet, T., Chui, D., Paulson, J.C. & Marth, J.D. Immune regulation by the ST6Gal sialyltransferase. Proc. Natl. Acad. Sci. USA 95, 4504–4509 (1998).
John, B. et al. The B cell coreceptor CD22 associates with AP50, a clathrin-coated pit adapter protein, via tyrosine-dependent interaction. J. Immunol. 170, 3534–3543 (2003).
Xu, Z. & Weiss, A. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat. Immunol. 3, 764–771 (2002).
Lanoue, A., Batista, F.D., Stewart, M. & Neuberger, M.S. Interaction of CD22 with α2,6-linked sialoglycoconjugates: innate recognition of self to dampen B cell autoreactivity? Eur. J. Immunol. 32, 348–355 (2002).
Collins, B.E. et al. Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact. Proc. Natl. Acad. Sci. USA 101, 6104–6109 (2004).
Crocker, P.R. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling. Curr. Opin. Struct. Biol. 12, 609–615 (2002).
Acknowledgements
We wish to thank M. Pawlita for the K20 cell line, A. Varki for the plasmid encoding for CD22-Fc plasmid, O. Blixt for the Galβ1-4GlcNAcβ-Lc-Lc-biotin, H. Li and M. Iufer for expert technical assistance, L.K. Allin for preparation of enzymes used in synthesis, and A. Tran-Crie for assistance in manuscript preparation. This work was funded by the US National Institutes of Health grants GM60938 and AI050143 and a Wenner-Gren Foundation fellowship to P.B.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
Requirement of UV light for crosslinking of CD22 in situ. (PDF 592 kb)
Supplementary Fig. 2
Demonstration of equivalent biotinylation of cell preparations used for SNA and CD22-Fc immunoprecipitations in. (PDF 434 kb)
Supplementary Fig. 3
CD45, CD19, and PMCA can be immunoprecipitated by CD22-Fc in a sialic acid dependent manner. (PDF 561 kb)
Supplementary Fig. 4
Absence of CD22 crosslinking to CD19 or CD45. (PDF 419 kb)
Supplementary Fig. 5
Comparison of CD22 crosslinking in resting and activated K20 cells. (PDF 699 kb)
Supplementary Fig. 6
CD22 interacts in cis with glycans on neighboring CD22 molecules to form homo-multimeric complexes. (PDF 488 kb)
Rights and permissions
About this article
Cite this article
Han, S., Collins, B., Bengtson, P. et al. Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking. Nat Chem Biol 1, 93–97 (2005). https://doi.org/10.1038/nchembio713
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio713
This article is cited by
-
A (cross)link in the chains
Nature Chemistry (2023)
-
Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection
Cellular & Molecular Immunology (2023)
-
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
Nature Reviews Drug Discovery (2021)
-
A CD22–Shp1 phosphatase axis controls integrin β7 display and B cell function in mucosal immunity
Nature Immunology (2021)
-
Bacterial lectin BambL acts as a B cell superantigen
Cellular and Molecular Life Sciences (2021)